Følg
Usman Baber
Usman Baber
University of Oklahoma Health Sciences Center
Verificeret mail på ouhsc.edu
Titel
Citeret af
Citeret af
År
Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease
S Jaiswal, P Natarajan, AJ Silver, CJ Gibson, AG Bick, E Shvartz, ...
New England Journal of Medicine 377 (2), 111-121, 2017
22062017
Genetic risk, adherence to a healthy lifestyle, and coronary disease
AV Khera, CA Emdin, I Drake, P Natarajan, AG Bick, NR Cook, ...
New England Journal of Medicine 375 (24), 2349-2358, 2016
13982016
Ticagrelor with or without aspirin in high-risk patients after PCI
R Mehran, U Baber, SK Sharma, DJ Cohen, DJ Angiolillo, C Briguori, ...
New England Journal of Medicine 381 (21), 2032-2042, 2019
8992019
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study
R Mehran, U Baber, PG Steg, C Ariti, G Weisz, B Witzenbichler, TD Henry, ...
The Lancet 382 (9906), 1714-1722, 2013
6842013
Comparison of propensity score methods and covariate adjustment: evaluation in 4 cardiovascular studies
MC Elze, J Gregson, U Baber, E Williamson, S Sartori, R Mehran, ...
Journal of the American College of Cardiology 69 (3), 345-357, 2017
6622017
Exome-wide association study of plasma lipids in> 300,000 individuals
DJ Liu, GM Peloso, H Yu, AS Butterworth, X Wang, A Mahajan, ...
Nature genetics 49 (12), 1758-1766, 2017
5572017
Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting
P Natarajan, R Young, NO Stitziel, S Padmanabhan, U Baber, R Mehran, ...
Circulation 135 (22), 2091-2101, 2017
5342017
Coronary thrombosis and major bleeding after PCI with drug-eluting stents: risk scores from PARIS
U Baber, R Mehran, G Giustino, DJ Cohen, TD Henry, S Sartori, C Ariti, ...
Journal of the American College of Cardiology 67 (19), 2224-2234, 2016
5292016
Prevalence, impact, and predictive value of detecting subclinical coronary and carotid atherosclerosis in asymptomatic adults: the BioImage study
U Baber, R Mehran, S Sartori, MM Schoos, H Sillesen, P Muntendam, ...
Journal of the American College of Cardiology 65 (11), 1065-1074, 2015
5122015
Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials
G Giustino, U Baber, S Sartori, R Mehran, I Mastoris, AS Kini, SK Sharma, ...
Journal of the American College of Cardiology 65 (13), 1298-1310, 2015
3992015
Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study
U Baber, VJ Howard, JL Halperin, EZ Soliman, X Zhang, W McClellan, ...
Circulation: Arrhythmia and Electrophysiology 4 (1), 26-32, 2011
3472011
Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials
U Baber, R Mehran, SK Sharma, S Brar, J Yu, JW Suh, HS Kim, SJ Park, ...
Journal of the American College of Cardiology 58 (15), 1569-1577, 2011
3292011
Machine learning prediction in cardiovascular diseases: a meta-analysis
C Krittanawong, HUH Virk, S Bangalore, Z Wang, KW Johnson, R Pinotti, ...
Scientific reports 10 (1), 16057, 2020
3232020
Deep learning for cardiovascular medicine: a practical primer
C Krittanawong, KW Johnson, RS Rosenson, Z Wang, M Aydar, U Baber, ...
European heart journal 40 (25), 2058-2073, 2019
3122019
Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy)
AS Kini, U Baber, JC Kovacic, A Limaye, ZA Ali, J Sweeny, A Maehara, ...
Journal of the American College of Cardiology 62 (1), 21-29, 2013
2962013
Duration of dual antiplatelet therapy: a systematic review for the 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary …
JA Bittl, U Baber, SM Bradley, DN Wijeysundera
Journal of the American College of Cardiology 68 (10), 1116-1139, 2016
2862016
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
D Capodanno, R Mehran, M Valgimigli, U Baber, S Windecker, P Vranckx, ...
Nature Reviews Cardiology 15 (8), 480-496, 2018
2132018
Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR
NM Van Mieghem, M Unverdorben, C Hengstenberg, H Moellmann, ...
New England Journal of Medicine 385 (23), 2150-2160, 2021
2032021
Sex-based differences in outcomes with transcatheter aortic valve therapy: TVT registry from 2011 to 2014
J Chandrasekhar, G Dangas, J Yu, S Vemulapalli, S Suchindran, AN Vora, ...
Journal of the American College of Cardiology 68 (25), 2733-2744, 2016
2012016
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials
P Guedeney, G Giustino, S Sorrentino, BE Claessen, A Camaj, ...
European heart journal 43 (7), e17-e25, 2022
1972022
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20